-
1
-
-
66549127501
-
ACCF/A H A 2009 expert consensus document on pulmonary hypertension: A report of the American college of cardiology foundation task force on expert consensus documents and the American heart association: Developed in collaboration with the American college of chest physicians, American thoracic society, inc., and the pulmonary hypertension association
-
McLaughlin V.V., Archer SL, Badesch D.B., et al.: ACCF/A H A 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119: 2250-2294, 2009.
-
(2009)
Circulation
, vol.119
, pp. 2250-2294
-
-
McLaughlin, V.V.1
Archer, S.L.2
Badesch, D.B.3
-
2
-
-
0024449294
-
Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the national heart, lung, and blood institute, primary pulmonary hypertension registry
-
Pietra GG, Edwards WD, Kay J.M., et al.: Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 80: 1198-1206, 1989.
-
(1989)
Circulation
, vol.80
, pp. 1198-1206
-
-
Pietra, G.G.1
Edwards, W.D.2
Kay, J.M.3
-
3
-
-
0031470417
-
Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morpho-genetic protein-2
-
Nakaoka T, Gonda K, Ogita T., et al.: Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morpho-genetic protein-2. J Clin Invest 100: 2824-2832, 1997.
-
(1997)
J Clin Invest
, vol.100
, pp. 2824-2832
-
-
Nakaoka, T.1
Gonda, K.2
Ogita, T.3
-
4
-
-
43049092988
-
An antipro-liferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension
-
Hansmann G, de Jesus Perez VA, Alastalo T P, et al.: An antipro-liferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118: 1846-1857, 2008.
-
(2008)
J Clin Invest
, vol.118
, pp. 1846-1857
-
-
Hansmann, G.1
De Jesus Perez, V.A.2
Alastalo, T.P.3
-
5
-
-
77950485024
-
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model
-
Nisbet RE, Bland JM, Kleinhenz D.J., et al.: Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol 42: 482-490, 2010.
-
(2010)
Am J Respir Cell Mol Biol
, vol.42
, pp. 482-490
-
-
Nisbet, R.E.1
Bland, J.M.2
Kleinhenz, D.J.3
-
6
-
-
20444439570
-
PPAR-gamma modulates allergic inflam-mation through up-regulation of PTEN
-
Lee KS, Park SJ, Hwang P.H., Yi HK, Song CH, Chai OH, Kim J.S., Lee MK and Lee YC: PPAR-gamma modulates allergic inflam-mation through up-regulation of PTEN. FASEB J 19: 1033-1035, 20 05.
-
(2005)
FASEB J
, vol.19
, pp. 1033-1035
-
-
Lee, K.S.1
Park, S.J.2
Hwang, P.H.3
Yi, H.K.4
Song, C.H.5
Chai, O.H.6
Kim, J.S.7
Lee, M.K.8
Lee, Y.C.9
-
7
-
-
33751167878
-
PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404
-
Zhang W, Wu N, Li Z.X., Wang LY, Jin JW and Zha XL: PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404. Cancer Biol Ther 5: 1008-1014, 2006.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1008-1014
-
-
Zhang, W.1
Wu, N.2
Li, Z.X.3
Wang, L.Y.4
Jin, J.W.5
Zha, X.L.6
-
8
-
-
77951950431
-
Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease
-
Ye L, Haider KhH, Esa WB, et al.: Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease. J Cell Mol Med 14: 323-336, 2010.
-
(2010)
J Cell Mol Med
, vol.14
, pp. 323-336
-
-
Ye, L.1
Haider, Kh.H.2
Esa, W.B.3
-
9
-
-
68449102187
-
Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus
-
Ye L, Lee KO, Su L P, et al.: Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus. Diabetologia 52: 1925-1934, 2009.
-
(2009)
Diabetologia
, vol.52
, pp. 1925-1934
-
-
Ye, L.1
Lee, K.O.2
Su, L.P.3
-
10
-
-
17944386754
-
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells
-
Zhang S, Fantozzi I, Tigno D.D., et al.: Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L74 0 - L75 4, 2 0 0 3.
-
(2003)
Am J Physiol Lung Cell Mol Physiol
, vol.285
-
-
Zhang, S.1
Fantozzi, I.2
Tigno, D.D.3
-
11
-
-
2942603006
-
Diagnosis and differential assessment of pulmonary arterial hypertension
-
Barst RJ, McGoon M, Torbicki A., Sitbon O, Krowka MJ, Olschewski H and Gaine S: Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43: 40S-47S, 2004.
-
(2004)
J Am Coll Cardiol
, vol.43
-
-
Barst, R.J.1
McGoon, M.2
Torbicki, A.3
Sitbon, O.4
Krowka, M.J.5
Olschewski, H.6
Gaine, S.7
-
12
-
-
0038389113
-
Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth
-
Ameshima S, Golpon H, Cool C.D., et al.: Peroxisome proliferator- activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92: 1162-1169, 2003.
-
(2003)
Circ Res
, vol.92
, pp. 1162-1169
-
-
Ameshima, S.1
Golpon, H.2
Cool, C.D.3
-
13
-
-
33751533892
-
International union of pharmacology. LXI. Peroxisome proliferator- activated receptors
-
Michalik L, Auwerx J, Berger J P, et al.: International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58: 726-741, 2006.
-
(2006)
Pharmacol Rev
, vol.58
, pp. 726-741
-
-
Michalik, L.1
Auwerx, J.2
Berger, J.P.3
-
14
-
-
21344461418
-
Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats
-
(In Japanese)
-
Matsuda Y, Hoshikawa Y, Ameshima S., et al.: Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats. Nihon Kokyuki Gakkai Zasshi 43: 283-288, 2005 (In Japanese).
-
(2005)
Nihon Kokyuki Gakkai Zasshi
, vol.43
, pp. 283-288
-
-
Matsuda, Y.1
Hoshikawa, Y.2
Ameshima, S.3
-
16
-
-
33947731898
-
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation
-
Hansmann G, Wagner RA, Schellong S, et al.: Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115: 1275-1284, 2007.
-
(2007)
Circulation
, vol.115
, pp. 1275-1284
-
-
Hansmann, G.1
Wagner, R.A.2
Schellong, S.3
-
17
-
-
33646434260
-
Increased PTEN expression due to transcriptional activation of PPARgamma by lovastatin and rosiglitazone
-
Teresi RE, Shaiu C, Chen C., Chatterjee K, Waite KA and Eng C: Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer 118: 2390-2398, 2006.
-
(2006)
Int J Cancer
, vol.118
, pp. 2390-2398
-
-
Teresi, R.E.1
Shaiu, C.2
Chen, C.3
Chatterjee, K.4
Waite, K.A.5
Eng, C.6
-
18
-
-
0035032219
-
Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation
-
Minamino T, Mitsialis SA and Kourembanas S: Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 21: 3336-3342, 2001.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 3336-3342
-
-
Minamino, T.1
Mitsialis, S.A.2
Kourembanas, S.3
-
19
-
-
0032577699
-
The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phospha-tidylinositol 3, 4, 5-trisphosphate
-
Maehama T and Dixon JE: The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phospha-tidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273: 13375-13378, 1998.
-
(1998)
J Biol Chem
, vol.273
, pp. 13375-13378
-
-
Maehama, T.1
Dixon, J.E.2
|